Tumor fraction-based prognostic tool for cancer patients referred to early phase clinical trials.
Bayle A, Belcaid L, Cousin S, Trin K, Alame M, Rouleau E, Soubeyran I, Lacroix L, Blouin L, Vasseur D, Crombe A, Mathoulin-Pelissier S, Soria JC, Bellera C, Italiano A.
Bayle A, et al. Among authors: trin k.
NPJ Precis Oncol. 2024 Oct 7;8(1):227. doi: 10.1038/s41698-024-00685-9.
NPJ Precis Oncol. 2024.
PMID: 39375508
Free PMC article.